Staar Surgical STAA Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 76.9%+0.7pp | 76.2%+2.3pp | 73.9%+2.2pp | 71.7%-2.3pp | 74%-2.3pp | |
| Operating margin | -9.1%+29.2pp | -38.3%+3.7pp | -42%+6.9pp | -48.8%-24.6pp | -24.3%-20.2pp | |
| Net margin | -7.2%+26.4pp | -33.6%+8.2pp | -41.8%+0.7pp | -42.4%-17.0pp | -25.5%-19.0pp | |
| EBITDA margin | -6.3%+28.5pp | -34.8%+3.4pp | -38.2%+6.9pp | -45.1%-23.7pp | -21.4%-19.6pp | |
| Free cash flow margin | -19.6%-2.1pp | -17.5%+0.5pp | -17.9%— | —— | —— | |
| Returns | ||||||
| Return on equity | -6%+15.7pp | -21.7%+3.0pp | -24.6%+0.9pp | -25.6%-6.4pp | -19.1%-14.0pp | |
| Return on assets | -4.6%+12.1pp | -16.7%+2.7pp | -19.4%+0.7pp | -20%-5.1pp | -15%-10.9pp | |
| Return on invested capital | -11.2%+24.0pp | -35.2%+2.0pp | -37.2%+10.2pp | -47.4%-15.0pp | -32.4%-27.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.5×0.0× | 0.5×0.0× | 0.5×-0.1× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 5.1×+0.6× | 4.5×-0.7× | 5.2×+0.3× | 4.9×+0.2× | 4.8×-0.5× | |
| Quick ratio | 5.2×+0.7× | 4.5×-0.7× | 5.2×+0.3× | 4.9×+0.2× | 4.7×-0.5× | |
| Cash ratio | 2.2×-0.1× | 2.2×-0.6× | 2.9×0.0× | 2.8×+0.3× | 2.5×+0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -6.4×+13.6× | -20×-0.9× | -19.1×+0.2× | -19.3×-7.5× | -11.8×-9.6× | |
| Per Share | ||||||
| Book value per share | $6.92-0.3% | $6.94-0.8% | $7.00+3.0% | $6.80-4.2% | $7.09-12.3% | |
| Valuation | ||||||
| Market capitalization | $1.55B+92.0% | $935.48M-26.7% | $1.28B+43.9% | $887.26M+0.2% | $885.53M-25.7% | |
| Enterprise value | $1.46B+117% | $820.69M-28.0% | $1.14B+49.9% | $760.65M+1.5% | $749.09M-31.1% | |
| Price / sales | 5.4×+2.5× | 3.9×-1.6× | 5.5×+1.6× | 4×+0.8× | 3.2×-0.6× | |
| Price / book | 4.4×+2.1× | 2.7×-0.9× | 3.6×+1.0× | 2.6×+0.1× | 2.5×-0.5× | |
| EV / sales | 5×+2.6× | 3.4×-1.5× | 4.9×+1.6× | 3.4×+0.7× | 2.7×-0.8× | |
| Free cash flow yield | -3.7%+0.2pp | -4.5%-1.2pp | -3.2%— | —— | —— | |
| Earnings yield | -1.4%+7.4pp | -8.6%-1.1pp | -7.5%+3.2pp | -10.7%-2.7pp | -8%-6.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Staar Surgical's profit margins?
- Staar Surgical (STAA) runs a 76.9% gross margin and a -9.1% operating margin, with a -7.2% net margin.
- Where do Staar Surgical's ratios come from?
- Every ratio is computed from Staar Surgical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
